Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
GERMANY INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... over the forecast period. One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in ... Read More
-
North America Blood Glucose Monitoring Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period, 2022-2027. In North America, diabetes incidence for Type-2 diabetes and other diabetes forms was numerically higher in individuals with COVID-19. Insulin resistance and impaired insulin secretion have been described in individuals without diabetes history ... Read More
-
North America Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2022-2027. In North America, till April 2022, the United States is having the highest COVID cases with 82 million, the country also registered the highest death rate. According to the Diabetes Voice article published in ... Read More
-
LATIN AMERICA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The COVID-19 pandemic has been testing the capacity to respond and adapt to populations, governments, and health systems worldwide. In the Latin America region, Brazil presented the first suspected and the first confirmed cases ... Read More
-
Asia-Pacific Biguanide Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... estimated to reach a value of more than USD 2 billion by 2027. The COVID-19 pandemic positively impacted the Asia-Pacific Biguanide Market. According to a study by BeatO in 2021 on 800 people, patients with ... Read More
-
EGYPT DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period (2022-2027). The market is estimated to reach a value of more than USD 430 million by 2027. The COVID-19 pandemic positively impacted the Egypt diabetes care devices market growth. Patients with diabetes, infected with ... Read More
-
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 7 molecules. Out of which approximately 2 molecules are developed by companies and remaining by the universities/institutes. The latest ... Read More
-
UNITED STATES INSULIN DRUGS AND DELIVERY DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... than 2.5% over the forecast period. Since the start of the epidemic, the United States has recorded 79 million cases of COVID-19. Over 960,000 people have died in the United States because of COVID-19. The ... Read More
-
Diabetic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Diabetic Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy, a common complication of diabetes, is damage to the nerves that allow feeling things such as pain. Symptoms include tingling, numbness, burning ... Read More
-
EUROPE DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The COVID-19 pandemic has substantially impacted the Europe Diabetes Care Devices Market. People with diabetes have a weak immune system so, with COVID-19, the immune system gets weaker very fast. People with diabetes will ... Read More
-
IRAN DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... measures interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic care, and a lack of the necessary infrastructure for telehealth services are the most significant challenges of diabetes care management ... Read More
-
ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... COVID-19 pandemic positively impacted the Asia-Pacific Diabetes Care Devices Market growth. Patients with diabetes, infected with COVID-19 may experience elevated blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in people with ... Read More
-
GERMANY BLOOD GLUCOSE MONITORING MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in diabetes mellitus, such as ... Read More
-
CANADA DIABETES CARE DRUGS AND DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... forecast period, 2022-2027. Canada has 107,861 cases of coronavirus disease 2019 (COVID-19) (286 per 1,00,000 individuals) and 8787 COVID-19-related fatalities as of July 13, 2020. In Canada, public health is overseen at the federal, provincial, ... Read More
-
BLOOD GLUCOSE TEST STRIPS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... of 2022-2027. The market is estimated to reach more than USD 13 billion by 2027. The COVID-19 pandemic positively impacted the blood glucose test strips market growth. Patients with diabetes injected with SARS-CoV-2 may experience ... Read More
-
LATIN AMERICA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... forecast period 2022-2027. The COVID-19 pandemic has substantially impacted the Latin America Diabetes Care Devices Market. People with diabetes have a weak immune system so, with COVID-19, the immune system gets weaker very fast. People ... Read More
-
RUSSIA DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Russia has the ninth-highest number of confirmed cases in the world affected by COVID-19. ... Read More
-
INODESIA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... The coronavirus disease 2019 (COVID-19) pandemic is a catastrophic global public health crisis caused by the SARS coronavirus 2 (SARS-CoV-2) virus. COVID-19 has a broad clinical spectrum, with symptoms ranging from asymptomatic to severe illness, ... Read More
-
Europe Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... The COVID-19 pandemic has had a significant impact on the market studied. Type-1 diabetes patients have been more affected during the pandemic since people with diabetes have weak immune systems. People with diabetes are also ... Read More
-
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a ... Read More
-
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Diabetes) - Drugs In Development, 2022, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D) is an autoimmune disease in which a pancreas stops producing insulin, ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
OMAN DIABETES CARE DEVICES MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period (2022-2027). The market is estimated to reach a value of more than USD 71 million by 2027. The COVID-19 pandemic positively impacted the Diabetes Care Devices market growth in Oman. Patients with diabetes, infected ... Read More
-
UNITED STATES DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... period, 2022-2027. COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including those who never contracted the virus. Because, when the epidemic struck, those with the chronic ... Read More
-
THAILAND DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... The healthcare system was significantly disturbed and pressured during each phase of rapid COVID-19 infection. Several countries, notably the Thai government, have introduced home isolation or a home quarantine program to avert healthcare collapse and ... Read More
Research Assistance
